We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App




Greiner Bio-One Launches Tube Holder for Blood Collection

By LabMedica International staff writers
Posted on 18 Dec 2018
Greiner Bio One International (Kremsmünster, Oberösterreich, Austria) has launched the innovative VACUETTE SAFELINK tube holder with male luer lock that facilitates quick and easy blood collection. More...
The tube offers simple handling and can be used in combination with all medical products that have a standard female luer lock connection, such as winged cannulae.

Greiner Bio-One develops collection systems for human and veterinary samples that make the flow of daily routine tasks in hospitals, laboratories or doctors' surgeries simpler and safer. The company offers sample collection products made out of plastic and also provides custom-made solutions. Greiner Bio-One’s VACUETTE product line is used in hospitals, laboratories, doctors’ offices and blood donor centers in more than 100 countries across the world.

The company has now added VACUETTE SAFELINK tube holder to its product line that comes with a luer lock feature, setting it apart from the conventional Greiner Bio-One tube holders and making it particularly suitable for blood collection from venous access devices according to guideline recommendations (Infusion Therapy Standard of Practice, Revised 2016).

Furthermore, VACUETTE SAFELINK, which is manufactured from unbreakable plastic and does not contain natural rubber latex, offers a secure screw connection between the holder and collection product to ensure safe and successful blood collection. With a controlled threading movement, the single-use product connects safely and smoothly to the respective medical device. Tests have shown that the secure connection can withstand pressures of up to 185mmHg, which combined with its functional design and practical handling, could contribute significantly to increased efficiency in everyday healthcare situations.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.